Clinical Trials Directory

Trials / Unknown

UnknownNCT05328518

Soft Tissue Tenderness and Fibromyalgia Among Schizophrenia Patients.

Status
Unknown
Phase
Study type
Observational
Enrollment
286 (estimated)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Numerous studies reported on comorbidity of fibromyalgia and psychiatric disorders. Approximately 30% of patients with fibromyalgia have major depression at the time of diagnosis; the lifetime prevalence of depression is 74% and that of an anxiety disorder is 60%. In some fibromyalgia patients, mood and cognitive problems are much more prominent than tenderness. From the psychiatric point of view, 49% of PTSD patients and 5% of major depression patients fulfill criteria for diagnosing fibromyalgia. The association between schizophrenia and fibromyalgia is still unknown. Study hypothesis Schizophrenia patients, who have an aberrant sensation of pain, have lower prevalence of FM compared to the general population. Primary objectives 1. Demonstrate that schizophrenia patients have lower prevalence of FM, compared to the general population. 2. To compare the self-reported extent and intensity of pain with selected tender points examination.

Conditions

Timeline

Start date
2021-06-10
Primary completion
2024-06-10
Completion
2024-09-10
First posted
2022-04-14
Last updated
2022-04-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT05328518. Inclusion in this directory is not an endorsement.